119
Participants
Start Date
November 30, 2016
Primary Completion Date
August 31, 2018
Study Completion Date
August 31, 2018
CS16-003 Full dose
350 mg 'Rhodiola rosea L. \& Rhaptonticum carthamoides extracts
CS16-003 Half dose
175 mg 'Rhodiola rosea L. \& Rhaptonticum carthamoides extracts + maltodextrin 175 mg
Placebo
Maltodextrin: 350 mg
University of North Carolina, Department of Exercise and Sport Science, Chapel Hill
Givaudan France Naturals
INDUSTRY
University of North Carolina, Chapel Hill
OTHER